Epilepsy Visit Planner for Epilepsy
Trial Summary
What is the purpose of this trial?
The purpose of this project is to conduct a trial to assess whether patients that receive a tablet-based waiting room priority communication tool (the "Epilepsy Visit Planner") have improved outcomes compared to patients that do not receive the tool. The project's hypotheses are: * Patients that receive the Epilepsy Visit Planner will have improved patient-provider communication compared to the non-planner group. * Patients that receive the Epilepsy Visit Planner will have improved quality of life scores. * The Epilepsy Visit Planner will score highly on process measures of feasibility and acceptability, demonstrating suitability for future larger scale study. Additionally, there is a related survey project that is not part of the clinical trial and will not be included in this registration information.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on using a communication tool rather than changing medication.
What data supports the effectiveness of the treatment Epilepsy Visit Planner, Tablet-based Waiting Room Priority Communication Tool for epilepsy?
The research suggests that having a seizure action plan (SAP) can help patients and caregivers manage seizure emergencies more effectively, which may be similar to the benefits of using a communication tool like the Epilepsy Visit Planner. Additionally, telehealth tools have been shown to improve communication and care in pediatric epilepsy, indicating that technology-based solutions can be beneficial in managing epilepsy.12345
How does the Epilepsy Visit Planner treatment differ from other epilepsy treatments?
The Epilepsy Visit Planner treatment is unique because it focuses on personalized care planning and communication between patients and healthcare providers, rather than a specific medication or therapy. It emphasizes creating individualized seizure action plans to manage seizure clusters effectively, which is not typically a focus of standard epilepsy treatments.12678
Research Team
Chloe Hill, MD
Principal Investigator
University of Michigan
Eligibility Criteria
This trial is for adults with drug-resistant epilepsy who are being treated at the University of Michigan's Epilepsy clinics. Participants must be able to complete study questionnaires in English and not have cognitive impairments that would prevent this.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Baseline assessments including Perceived Efficacy in Patient-Physician Interactions Questionnaire (PEPPI) and other measures
Intervention
Participants receive the Epilepsy Visit Planner tool and undergo assessments for feasibility and acceptability
Follow-up
Participants are monitored for quality of life and other outcomes 3 months after baseline
Treatment Details
Interventions
- Epilepsy Visit Planner
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator